As anesthesiologists, the 2 biggest things we do are airways — and
everything else. With any new device here, I want to see how it would
be different from what I already have. Is it an improvement? Is it
smaller, faster, cheaper, more efficient? Is the rate of complications
lower? I also come here to learn about the latest developments in the
drugs we use — old drugs being reintroduced, new drugs just hitting
the scene, new indications for existing drugs. Here are some of the
more interesting and relevant products I saw roaming the exhibit hall
at ASA 2019.
OSM
D E C E M B E R 2 0 1 9 • O U T PA T I E N T S U R G E R Y. N E T • 1 0 5
Dr. Sinha (drashish.sinha@gmail.com) is a professior at the University of
California Riverside, and designated institutional official (DIO) and program
director of anesthesiology at UC Riverside/Riverside Community Hospital.
Merck & Co.
Bridion
merckconnect.com
Each single-use vial of Bridion (sugammadex)
for reversing neuromuscular blockade con-
tains a concentration of 100 mg/mL of sugam-
madex. Dosing is based on actual body weight
and depth of block — 2 mg/kg for a moderate
block and 4 mg/kg for a deep block. Vials
include a peel-off label that you can apply to
the syringe. Routine co-administration of an
anticholinergic agent is not required, says the
company. Bridion is contraindicated in
patients with known hypersensitivity to sug-
ammadex or any of its components.